Research Article
Plasma Total Cysteine and Cardiovascular Risk Burden: Action and Interaction
Table 2
Redox characteristics according to risk factors burden.
| | All patients () | Group 0 () | Group 1 () | Group 2 () | Group 3 () |
| Plasma total thiols (μm/L) | | | | | | Homocysteine | 9.5 [7.4; 14.1] | 9.0 [7.1; 10.9] | 9.2 [7.4; 13.8] | 11.5 [7.8; 18.6] | 9.9 [7.5; 19.0] | Cysteine | 250 [210; 291] | 228 [197; 269] | 253 [203; 280] | 260 [223; 305] | 280 [230; 320] | Cysteinylglycine | 30.8 [23.9; 41.9] | 32.7 [24.7; 43.4] | 30.2 [24.0; 44.0] | 31.1 [23.7; 37.6] | 29.9 [22.4; 37.3] | Glutathione | 5.5 [4.1; 7.3] | 5.9 [4.3; 8.0] | 5.6 [4.0; 7.0] | 5.4 [4.2; 7.3] | 5.5 [3.7; 0.7.5] | Plasma reduced thiols (μm/L) | | | | | | Homocysteine | 0.16 [0.10; 0.24] | 0.13 [0.10; 0.21] | 0.16 [0.10; 0.24] | 0.19 [0.11; 0.29] | 0.14 [0.07; 0.28] | Cysteine | 7.9 [5.7; 9.4] | 7.9 [6.2; 9.0] | 7.7 [5.7; 9.1] | 7.9 [5.7; 10.0] | 8.1 [5.7; 10.1] | Cysteinylglycine | 3.3 [2.1; 4.5] | 3.5 [2.2; 5.3] | 3.5 [2.1; 4.9] | 3.3 [2.2; 4.3] | 2.9 [1.4; 3.7] | Glutathione | 1.9 [1.3; 3.8] | 1.9 [1.3; 3.9] | 1.8 [1.1; 3.5] | 2.1 [1.4; 4.2] | 2.1 [1.3; 4.4] | Free malondialdehyde (μmol/L) | 0.76 [0.47; 1.35] | 0.62 [0.36; 0.89] | 0.70 [0.45; 1.30] | 0.94 [0.68; 1.33] | 1.26 [0.65; 1.49] | Blood reduced glutathione (μmol/L) | 655 [496; 824] | 655 [451; 821] | 705 [536; 859] | 663 [454; 842] | 569 [499; 771] |
|
|
Data are expressed as median value and interquartile range [I; III].
|